Investigating Incubators & Innovation with Mason Ailstock
Mason Ailstock, CEO of the Rowen Foundation, discusses incubators and their potential to promote innovation.
In this video interview, Mason Ailstock, CEO of the Rowen Foundation, talked to Grant Playter, associate editor, on the topic of incubators and their potential to promote innovation.
Rowen is a knowledge community in Metro Atlanta focused on fostering collaboration across industries, including those in the medical, environmental, and agricultural fields. In this interview, Mason touches on the current status of the Rowen Foundation, the importance of fostering collaboration in this manner, and how it can promote innovation in the biopharma industry.
Biotech EG 427 Raises €27 Million in Series B Funding to Advance Lead Genetic Medicine Candidate
February 24th 2025Co-led by Andera Partners and Bpifrance, the Series B financing will go toward an ongoing Phase Ib/IIa clinical study for EG 427’s lead candidate and to advance the company’s genetic medicines platform.
